Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles of cystic fibrosis patients

Journal of Clinical Microbiology

Volumn 48, Issue 4, 2010, Pages 1035-1039

  Magni, Annarita ^a   Trancassini, Maria ^a   Varesi, Paola ^a   Iebba, Valerio ^a   Curci, Anna ^a   Pecoraro, Claudia ^a   Cimino, Giuseppe ^a   Schippa, Serena ^a   Quattrucci, Serena ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACHROMOBACTER XYLOSOXIDANS; ADULT; AGGLOMERATIVE HIERARCHICAL CLASSIFICATION; ANALYTIC METHOD; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL FLORA; BACTERIAL INFECTION; BACTERIAL STRAIN; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISCRIMINANT ANALYSIS; EXPIRATORY RESERVE VOLUME; FACTORIAL ANALYSIS; FEMALE; GENETIC CORRELATION; GENOME ANALYSIS; HUMAN; LUNG INFECTION; MALE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; SPIROMETRY;

ACHROMOBACTER DENITRIFICANS; ADOLESCENT; ADULT; BACTERIAL TYPING TECHNIQUES; CHILD, PRESCHOOL; CLUSTER ANALYSIS; CYSTIC FIBROSIS; DNA FINGERPRINTING; DNA, BACTERIAL; FEMALE; GENOTYPE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MOLECULAR EPIDEMIOLOGY; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; SPUTUM; YOUNG ADULT;

ACHROMOBACTER XYLOSOXIDANS; BACTERIA (MICROORGANISMS);

EID: 77950474340     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02060-09     Document Type: Article

References (25)

1. Cystic Fibrosis Foundation National Patient Registry. 1995. Annual report. Cystic Fibrosis Foundation, Bethesda, MD.
2. Cystic Fibrosis Foundation National Patient Registry. 2002. Annual report. Cystic Fibrosis Foundation, Bethesda, MD.
3. Dakin, C. J., A. H. Numa, H. Wang, J. R. Morton, C. C. Vertzyas, and R. L. Henry. 2002. Inflammation, infection, and pulmonary function in infant and young children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 165:904-910.
4. D'Argenio, D. A., M. Wu, L. R. Hoffman, H. D. Kulasekara, E. Déziel, E. E. Smith, H. Nguyen, R. K. Ernst, T. J. Larson Freeman, D. H. Spencer, M. Brittnacher, H. S. Hayden, S. Selgrade, M. Klausen, D. R. Goodlett, J. L. Burns, B. W. Ramsey, and S. I. Miller. 2007. Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol. Microbiol. 64:512-533.
5. Davies, J. C., and B. K. Rubin. 2007. Emerging and unusual gram-negative infections in cystic fibrosis. Semin. Respir. Crit. Care Med. 28:312-321.
6. Davis, P. B., M. Drumm, and M. W. Konstar. 1996. Cystic fibrosis. Am. J. Respir. Crit. Care Med. 154:1229-1256.
7. De Baets, F., P. Schelstraete, S. Van Daele, F. Haerynck, and M. Vaneechoutte. 2007. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance. J. Cyst. Fibros. 6:75-78.
8. Gómez-Cerezo, J., I. Suárez, J. J. Ríos, P. Peña, M. J. García de Miguel, M. de José, O. Monteagudo, P. Linares, A. Barbado-Cano, and J. J. Vázquez. 2003. Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases. Eur. J. Clin. Microbiol. Infect. Dis. 22:360-363.
9. Hansen, C. R., T. Pressler, K. G. Nielsen, P. Ø. Jensen, T. Bjarnsholt, and N. Høiby. 2009. Inflammation in Achromobacter xylosoxidans Infected cystic fibrosis patients. J. Cyst. Fibros. doi:10.1016/j.jcf.2009.10.005.
10. Hoboth, C., R. Hoffmann, A. Eichner, C. Henke, S. Schmoldt, A. Imhof, J. Heesemann, and M. Hogardt. 2009. Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. J. Infect. Dis. 200:118-130.
11. Hogardt, M., C. Hoboth, S. Schmoldt, C. Henke, L. Bader, and J. Heesemann. 2007. Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis. J. Infect. Dis. 195:70-80.
12. Krzewinski, J. W., C. D. Nguyen, J. M. Foster, and J. L. Burns. 2001. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis. J. Clin. Microbiol. 39:3597-3602.
13. Lambiase, A., V. Raia, M. Del Pezzo, A. Sepe, V. Carnovale, and F. Rossano. 2006. Microbiology of airway disease in a cohort of patients with cystic fibrosis. BMC Infect. Dis. doi:10.1186/1471-2334-6-4.
14. Liu, L., T. Coenyet, J. L. Burns, P. W. Whitby, T. L. Stull, and J. J. LiPuma. 2002. Ribosomal DNA-directed PCR for identification, of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients. J. Clin. Microbiol. 40:1210-1213.
15. Lyczak, J. B., C. L. Cannon, and G. B. Pier. 2002. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 15:194-222.
16. Mena, A., E. E. Smith, J. L. Burns, D. P. Speert, S. M. Moskowitz, J. L. Perez, and A. Oliver. 2008. Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation. J. Bacteriol. 190:7910-7917.
17. Nguyen, D., and P. K. Singh. 2006. Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections. Proc. Natl. Acad. Sci. USA 103:8305-8306.
18. Rajan, S., and L. Saiman. 2002. Pulmonary infections in patients with cystic fibrosis. Semin. Respir. Infect. 17:47-56.
19. Saiman, L., and J. Siegel. 2004. Infection control in cystic fibrosis. Clin. Microbiol. Rev. 17:57-71.
20. Spicuzza, L., C. Sciuto, G. Vitallti, G. Di Dio, S. Leonardi, and M. La Rosa. 2009. Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients. Eur. J. Clin. Microbiol. Infect. Dis. 28:191-195.
21. Steinkamp, G., B. Wiedemann, E. Rietschel, A. Krahl, J. Gielen, H. Bärmeier, and F. Ratjen. 2005. Prospective evaluation of emerging bacteria in cystic fibrosis. J. Cyst. Fibros. 4:41-48.
22. Tan, K., S. P. Conway, K. G. Brownlee, C. Etherington, and D. G. Peckham. 2002. Alcaligenes Infection in cystic fibrosis. Pediatr. Pulmonol. 34:101-104.
23. Tena, D., R. Carranza, J. R. Barberá, S. Valdezate, J. M. Garrancho, M. Arranz, and J. A. Sáez-Nieto. 2005. Outbreak of long-term intravascular catheter-related bacteremia due to Achromobacter xylosoxidans subspecies xylosoxidans in a haemodialysis unit. Eur. J. Clin. Microbiol. Infect. Dis. 24:727-732.
24. Vonberg, R. P., and P. Gastmeier. 2005. Isolation of Infectious cystic fibrosis patients: results of a systematic review. Infect. Control Hosp. Epidemiol. 26:401-409.
25. Weitkamp, J. H., Y. W. Tang, D. W. Haas, N. K. Midha, and J. E. Crowe, Jr. 2000. Recurrent Achromobacter xylosoxidans bacteremia associated with persistent lymph node infection in a patient with hyper-immunoglobulln M syndrome. Clin. Infect. Dis. 31:1183-1187.